Browse All

Current Filters

CLEAR FILTER x

TITLE

Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response

Author:Habib, Ali   Benatar, Michael   Vu, Tuan   Meisel, Andreas   Attarian, Shahram   Katsuno, Masahisa   Liao, Serena   Beasley, Kathleen   Howard, James   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.004  

Author Institution:University of California, Irvine, Orange, CA  University of Miami, Miami, FL  University of South Florida, Tampa, FL  Charité Universitätsmedizin Berlin, Berlin, Germany  CHU La Timone Aix Marseille University, Marseille, France  Nagoya University Graduate School of Medicine, Nagoya, Japan  Alexion, AstraZeneca Rare Disease, Boston, MA  The University of North Carolina, Chapel Hill, NC  

Blepharoclonus as a Potential Novel Clinical Marker in Parkinson’s Disease

Author:Beltre, Nestor   Feldman, Matthew   Marmol, Sarah   Shpiner, Danielle   Luca, Corneliu   Moore, Henry   Singer, Carlos   Wuu, Joanne   Benatar, Michael   Haq, Ihtsham   Margolesky, Jason   

Session Name:P3: Movement Disorders: Biomarkers and Genetics of Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P3.009  

Author Institution:Jackson Memorial Hospital / University of Miami Hospital, Miami, FL  Movement Disorders Fellowship - University of Miami, MIAMI, FL  University of Miami Hospital, Miami, FL  University of Miami Miller School of Medicine, Miami, FL  University of Miami, Miami, FL  University of Miami - Miller School of Medicine, Miami, FL  University of Miami, Fort Lauderdale, FL  Univ of Miami, Dept Of Neurology, Miami, FL  University of Miami School of Medicine, Miami, FL  

Identifying Digital Biomarkers for the Self-Monitoring of Patients Living with Generalized Myasthenia gravis: a Proof of Concept

Author:Laforet, Pascal   Orlikowski, David   Nicolas, Guillaume   Prigent, Hélène   Berling, Edouard   N'Dah-Sekou, Ghislain   Gorin, Clarissa   Moreira, Ana Júlia   Narcy, Juliette   Plaud, Angéline   Touré Cuq, Emma   Keller, Martin   Werneburg, Brian   Aras, Emrah   Benatar, Michael   

Session Name:P7: Neuromuscular Disease: Neuromuscular Junction Disorders 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.007  

Author Institution:Nord-Est/Ile-de-France Neuromuscular Reference Center, UMR 1179, Neurology Department, Raymond-Poincaré Hospital, Garches, and FHU PHENIX, France, Paris, France  Nord-Est/Ile-de-France Neuromuscular Reference Center, UMR 1179, CIC 1429, Neurology Department, Raymond-Poincaré Hospital, Garches and FHU PHENIX,UVSQ Paris-Saclay University, France, Paris, France  Ad Scientiam, Paris, France, Paris, France  Alexion Pharma GmbH, Giesshübelstrasse 30, 8045 Zürich, Switzerland, Zürich, Switzerland  Alexion Pharmaceuticals Inc., 121 Seaport Blvd, Boston, MA 02025, USA, Boston, MA  Department of Neurology, Emory University, GA, USA, Atlanta, GA  

OPTN: A Possible Genetic Cause of Both CBS and ALS

Author:Feldman, Matthew   Benatar, Michael   Saraf Lavi, Efrat   Latchman, Kumarie   Singer, Carlos   

Session Name:P9: Movement Disorders: Atypical Parkinsonisms 2  

Topic:Movement Disorders  

Program Number:P9.013  

Author Institution:University of Miami, Miami, FL  University of Miami, Fort Lauderdale, FL